TerSera Canada's goserelin acetate receives Health Canada approval for management of ER+ early breast cancer
TerSera Canada Inc, a biopharmaceutical company with a focus in oncology and urology, announced that Health Canada has approved a supplemental New Drug Submission for Zoladex LA (goserelin acetate) 10.8mg every 12 weeks for the management of estrogen …